Northsight Capital plans to acquire Stargreen Holdings to expand its business and presence in the cannabis industry.
Based on the purchase consideration, Northsight expects the acquisition to cost between $5m and $20m.
The company will issue 210 million of its common stock shares to raise funds for the acquisition.
GL Capital Management and ABG Management plan to acquire SciClone Pharma for a purchase consideration of $570m.
The companies plan to fund the acquisition through debt and equity financing.
Morgan Stanley is acting as transaction adviser, and Skadden Arps, Slate Meagher &Flom and Fangda Law Firm are acting as legal advisers for the acquisition.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataTonghua Golden Horse Pharmaceutical Industry plans to acquire medicinal materials firm Lhasa.
The company expects the acquisition to cost up to $1.6m.